1. |
McCarthy PA, Maino DM. Alport syndrome: a review[J]. Clin Eye Vis Care, 2000, 12(3-4): 139-150. DOI: 10.1016/S0953-4431(00)00042-4.
|
2. |
Usui T, Ichibe M, Hasegawa S, et al. Symmetrical reduced retinal thickness in a patient with Alport syndrome[J]. Retina, 2004, 24(6): 977-979. DOI: 10.1097/00006982-200412000-00026.
|
3. |
Ahmed F, Kamae KK, Jones DJ, et al. Temporal macular thinning associated with X-linked Alport syndrome[J]. JAMA Ophthalmol, 2013, 131(6): 777-782. DOI: 10.1001/jamaophthalmol.2013.1452.
|
4. |
Thomas AS, Baynham JT, Flaxel CJ. Macular holes, vitelliform lesions, and midperipheral retinoschisis in Alport syndrome[J]. Retin Cases Brief Rep, 2016, 10(2): 109-111. DOI: 10.1097/ICB.0000000000000176.
|
5. |
Zhang KW, Colville D, Tan R, et al. The use of ocular abnormalities to diagnose X-linked Alport syndrome in children[J]. Pediatr Nephrol, 2008, 23(8): 1245-1250. DOI: 10.1007/s00467-008-0759-4.
|
6. |
Wang Y, Sivakumar V, Mohammad M, et al. Clinical and genetic features in autosomal recessive and X-linked Alport syndrome[J]. Pediatr Nephrol, 2014, 29(3): 391-396. DOI: 10.1007/s00467-013-2643-0.
|
7. |
Jacobs M, Jeffrey B, Kriss A, et al. Ophthalmologic assessment of young patients with Alport syndrome[J]. Ophthalmology, 1992, 99(7): 1039-1044. DOI: 10.1016/S0161-6420(92)31853-6.
|
8. |
Savige J, Liu J, DeBuc DC, et al. Retinal basement membrane abnormalities and the retinopathy of Alport syndrome[J]. Invest Ophthalmol Vis Sci, 2010, 51(3): 1621-1627. DOI: 10.1167/iovs.08-3323.
|